H-CYS-VAL-2-NAL-MET-OH

H-CYS-VAL-2-NAL-MET-OH用途

H-Cys-Val-2-Nal-Met-OH是一种肽。H-Cys-Val-2-Nal-Met-OH是一种可用于标记短肽序列的拟肽衍生物[1]。
点击显示

H-CYS-VAL-2-NAL-MET-OH名称

[ CAS 号 ]:
158022-12-9

[ 中文名 ]:
H-CYS-VAL-2-NAL-MET-OH

[ 英文名 ]:
H-Cys-Val-2-Nal-Met-OH

[英文别名 ]:

H-CYS-VAL-2-NAL-MET-OH生物活性

[ 描述 ]:

H-Cys-Val-2-Nal-Met-OH是一种肽。H-Cys-Val-2-Nal-Met-OH是一种可用于标记短肽序列的拟肽衍生物[1]。

[ 相关类别 ]:

研究领域 >> 其他
信号通路 >> 其他 >> 其他

[参考文献]

[1]. Boschi A, et al. A novel approach to the high-specific-activity labeling of small peptides with the technetium-99m fragment [99mTc(N)(PXP)]2+ (PXP = diphosphine ligand). Bioconjug Chem. 2001 Nov-Dec;12(6):1035-42.  

H-CYS-VAL-2-NAL-MET-OH物理化学性质

[ 分子式 ]:
C26H36N4O5S2

[ 分子量 ]:
548.71800

[ 精确质量 ]:
548.21300

[ PSA ]:
214.72000

[ LogP ]:
3.46050

H-CYS-VAL-2-NAL-MET-OH安全信息

[ 个人防护装备 ]:
Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter

[ 危险品运输编码 ]:
NONH for all modes of transport

H-CYS-VAL-2-NAL-MET-OH文献

Nonfarnesylated tetrapeptide inhibitors of protein farnesyltransferase.

J. Biol. Chem. 266 , 15575-15578, (1991)

The protein farnesyltransferase from rat brain was previously shown to be inhibited competitively by tetrapeptides that conform to the consensus Cys-A1-A2-X, where A1 and A2 are aliphatic amino acids ...

Infectious tolerance via the consumption of essential amino acids and mTOR signaling.

Proc. Natl. Acad. Sci. U. S. A. 106 , 12055-60, (2009)

Infectious tolerance describes the process of CD4(+) regulatory T cells (Tregs) converting naïve T cells to become additional Tregs. We show that antigen-specific Tregs induce, within skin grafts and ...

Hamilton, A.D. and Sebti, S.M

Drug News Perspect. 8 , 138, (1995)


更多文献

推荐生产厂家/供应商:

暂无推荐供应商。请联系客服获知如何成为推荐供应商。


相关化合物

[H-CYS-VAL-2-NAL-MET-OH]化源网提供H-CYS-VAL-2-NAL-MET-OHCAS号158022-12-9,H-CYS-VAL-2-NAL-MET-OHMSDS及其说明、性质、英文名、生产厂家、作用/用途、分子量、密度、沸点、熔点、结构式等。CAS号查询H-CYS-VAL-2-NAL-MET-OH上化源网,专业又轻松。>>电脑版:H-CYS-VAL-2-NAL-MET-OH

标题:158022-12-9_H-CYS-VAL-2-NAL-MET-OHCAS号:158022-12-9_H-CYS-VAL-2-NAL-MET-OH【结构式 性质 英文】 - 化源网 地址:https://m.chemsrc.com/mip/cas/158022-12-9_832806.html